Biologics

After reporting lingering shoulder pain, St. Louis Cardinals pitcher Carlos Martinez received a platelet-rich plasma injection at Gulf Breeze, Fla.-based Andrews Institute for Orthopaedics and Sports Medicine, the St. Louis Post-Dispatch reports.

Daniel Birk, MD, director of the Neurosurgery Spine Center at Stony Brook (N.Y.) Medicine, discusses the biggest challenges and opportunities in spine device development today.

Neurosurgeons Mario Cahueque, MD, and Enrique Azmitia, MD, performed SpineFrontier's first SacroFuse and NanoFUSE case in Latin America.

Here are the top manufacturers in the orthopedic biomaterials market, according to a Market Expertz report.

Andrew Cordover, MD, a spine surgeon with Andrews Sports Medicine & Orthopaedic Center in Birmingham, Ala., discusses the key technology trends for 2019.

Andrew Hecht, MD, chief of spine surgery at The Mount Sinai Health System in New York City, outlines the key trends and big opportunities in the spine device space moving forward.

Here are five orthopedic and sports medicine surgeons using Lipogems, an FDA-cleared technology that uses the body's own adipose tissue to help heal injuries.

Kuros Biosciences entered into a private label agreement with SeaSpine.

Robert Watkins Jr., MD, performed his first surgery with the Osseus Fusion Systems Aries-L technology, which is currently in alpha launch.

Ann Arbor-based Michigan Medicine researchers are working to improve the Masquelet orthopedic surgical technique, according to MHealth Lab.